Peptonic Medical AB delays third-quarter financial report

Swedish health firm Peptonic Medical AB announced a delay in the release of its financial results for the third quarter of 2026. The report, initially scheduled for publication on November 10, will now be issued on November 26.

The company cited administrative reasons for the rescheduling. This adjustment shifts the date by sixteen days, pushing the disclosure into the latter half of November.

Peptonic Medical specializes in intimate self-care products for the women's health sector. Investors and market analysts await the report for clarity on the company's financial performance during the current fiscal year.